Open access
Open access
Powered by Google Translator Translator

Cohort Study: Analysis of neuropsychiatric diagnoses after montelukast initiation.

25 May, 2022 | 11:05h | UTC

Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation – JAMA Network Open


FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis – U.S. Food & Drug Administration

Adverse drug reactions of montelukast in children and adults – Pharmacology Research & Perspectives


Commentary on Twitter


Stay Updated in Your Specialty

No spam, just news.